Ken Griffin Medpace Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $1.54 Million - $2.19 Million	4,800 Added 29.45%	21,100 $7.04 Million
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $17.4 Million - $19.9 Million	-46,900 Reduced 74.21%	16,300 $6.71 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $14 Million - $20.4 Million	49,300 Added 354.68%	63,200 $25.5 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $1.52 Million - $2.09 Million	-6,700 Reduced 32.52%	13,900 $4.26 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $3.98 Million - $4.79 Million	17,000 Added 472.22%	20,600 $4.99 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $74,904 - $96,068	400 Added 12.5%	3,600 $864,000
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $4.57 Million - $6.28 Million	-26,200 Reduced 89.12%	3,200 $601,000
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $2.86 Million - $4.24 Million	18,700 Added 174.77%	29,400 $6.24 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $478,929 - $602,217	-3,300 Reduced 23.57%	10,700 $1.68 Million

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.